Massive MS registry tracks 1,000 patients to compare drug safety

NCT ID NCT03291756

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: CorEvitas Source: ClinicalTrials.gov ↗

Summary

This study is creating a national registry to track 1,000 people with multiple sclerosis (MS) over time. Researchers will compare how well different approved MS medications work in real-world settings and monitor their safety. The goal is to better understand MS patterns and treatment outcomes by collecting information from patients and their neurologists every six months during regular doctor visits.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CorEvitas, LLC

    Waltham, Massachusetts, 02451, United States

Conditions

Explore the condition pages connected to this study.